Olga Moser

844 total citations
19 papers, 239 citations indexed

About

Olga Moser is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Olga Moser has authored 19 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Olga Moser's work include Neutropenia and Cancer Infections (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Olga Moser is often cited by papers focused on Neutropenia and Cancer Infections (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Olga Moser collaborates with scholars based in Germany, Austria and Switzerland. Olga Moser's co-authors include Dagmar Dilloo, Gunnar Cario, Arne Simon, C. Stussi-Garaud, U. Bode, Norbert Graf, T. Godefroy-Colburn, Hans Nitschko, Rhoikos Furtwängler and Angela Wawer and has published in prestigious journals such as Scientific Reports, Journal of General Virology and British Journal of Haematology.

In The Last Decade

Olga Moser

19 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Moser Germany 9 77 70 60 45 30 19 239
Valeria Beckett United States 9 77 1.0× 22 0.3× 29 0.5× 12 0.3× 5 0.2× 14 388
DK Gupta India 10 53 0.7× 48 0.7× 43 0.7× 5 0.1× 13 0.4× 46 315
Jackie Rendall United Kingdom 10 75 1.0× 16 0.2× 130 2.2× 72 1.6× 6 0.2× 17 368
J Astruc France 10 77 1.0× 20 0.3× 51 0.8× 9 0.2× 7 0.2× 39 325
You La Jeon South Korea 10 95 1.2× 30 0.4× 68 1.1× 5 0.1× 8 0.3× 27 246
Kaj Lundgren Sweden 13 208 2.7× 21 0.3× 55 0.9× 10 0.2× 6 0.2× 19 480
Elizabeth I. Majeski United States 7 52 0.7× 36 0.5× 132 2.2× 5 0.1× 17 0.6× 8 338
Catherine de Magnée Belgium 11 47 0.6× 65 0.9× 18 0.3× 14 0.3× 20 0.7× 35 438
Elly Lugtenburg Netherlands 8 239 3.1× 77 1.1× 242 4.0× 9 0.2× 15 0.5× 17 358
Emma Paige Australia 8 151 2.0× 30 0.4× 109 1.8× 9 0.2× 5 0.2× 11 278

Countries citing papers authored by Olga Moser

Since Specialization
Citations

This map shows the geographic impact of Olga Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Moser more than expected).

Fields of papers citing papers by Olga Moser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Moser. The network helps show where Olga Moser may publish in the future.

Co-authorship network of co-authors of Olga Moser

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Moser. A scholar is included among the top collaborators of Olga Moser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Moser. Olga Moser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wagner, Norbert, Till Braunschweig, Robert Meyer, et al.. (2021). Aggressive infantile myofibromatosis with intestinal involvement. PubMed. 8(1). 7–7. 2 indexed citations
2.
Porto, Luciana, Se-Jong You, Andishe Attarbaschi, et al.. (2020). Invasive Mold Infection of the Central Nervous System in Immunocompromised Children. Journal of Fungi. 6(4). 226–226. 7 indexed citations
3.
Moser, Olga, Martin Zimmermann, Ulrike Meyer, et al.. (2020). Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group. Haematologica. 106(5). 1390–1400. 9 indexed citations
4.
Lehrnbecher, Thomas, Peter Rath, Andishe Attarbaschi, et al.. (2019). Galactomannan and PCR in the Central Nervous System to Detect Invasive Mold Disease - A Retrospective Analysis in Immunocompromised Children. Scientific Reports. 9(1). 12950–12950. 19 indexed citations
5.
Temming, Petra, Dietmar Lohmann, Dominik Sturm, et al.. (2019). Ectopic intracranial retinoblastoma in a 3.5‐month‐old infant without eye involvement and without evidence of heritability. Pediatric Blood & Cancer. 66(5). e27599–e27599. 2 indexed citations
6.
Lauten, Melchior, Andishe Attarbaschi, Gunnar Cario, et al.. (2019). Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: Analysis of 29 contemporary patients. Pediatric Blood & Cancer. 66(8). e27806–e27806. 22 indexed citations
7.
Grottke, Oliver, et al.. (2019). Plasma‐derived Factor X therapy for treatment of intracranial bleeding in a patient with Factor X deficiency: a case report. Transfusion. 59(7). 2228–2233. 7 indexed citations
8.
Kunstreich, Marina, Annika Bronsema, Kirsten Bleckmann, et al.. (2018). Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy. Leukemia & lymphoma. 60(1). 78–84. 10 indexed citations
9.
Ammann, Roland A., H.-J. Laws, Karoline Ehlert, et al.. (2015). Bloodstream infection in paediatric cancer centres—leukaemia and relapsed malignancies are independent risk factors. European Journal of Pediatrics. 174(5). 675–686. 58 indexed citations
10.
Bode, U., Martina Zimmermann, Olga Moser, et al.. (2014). Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial. Journal of Neuro-Oncology. 120(3). 635–642. 15 indexed citations
11.
Moser, Olga, Manuela Krumbholz, Christian Thiede, et al.. (2014). Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia. Pediatric Blood & Cancer. 61(11). 2080–2082. 5 indexed citations
12.
Glien, Alexander, Olga Moser, Friederike Göke, Kai Wilhelm, & Andreas O. H. Gerstner. (2012). Erstbeschreibung eines mesenchymalen Chondrosarkoms der Otobasis bei einem 9-jährigen Knaben. HNO. 60(12). 1086–1092. 1 indexed citations
13.
Moser, Olga, G. Fleischhack, Mark Born, et al.. (2011). Transiente Spleniumläsion bei Influenza-A-H1N1-09-Infektion. Der Radiologe. 51(3). 220–222. 6 indexed citations
14.
Fleischhack, Gudrun, Olga Moser, Dagmar Dilloo, et al.. (2011). Bloodstream Infections in Paediatric Cancer Patients. Prospective Comparative Study in 2 University Hospitals. Klinische Pädiatrie. 223(6). 335–340. 10 indexed citations
15.
Moser, Olga, et al.. (2011). Sapovirus as a gastrointestinal pathogen in febrile pediatric patients with cancer. Journal of Medical Virology. 83(12). 2233–2236. 10 indexed citations
17.
Landmann, Eva, Ilske Oschlies, Martin Zimmermann, et al.. (2008). Secondary non‐Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL. British Journal of Haematology. 143(3). 387–394. 5 indexed citations
18.
Moser, Olga, Marc Fuchs, L. Pinck, & C. Stussi-Garaud. (1992). Immunodetection of grapevine fanleaf virus satellite RNA-encoded protein in infected Chenopodium quinoa. Journal of General Virology. 73(11). 3033–3038. 7 indexed citations
19.
Moser, Olga, et al.. (1988). The Fate of the Transport Protein of Tobacco Mosaic Virus in Systemic and Hypersensitive Tobacco Hosts. Journal of General Virology. 69(6). 1367–1373. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026